326 related articles for article (PubMed ID: 25157833)
1. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.
Hao TB; Shi W; Shen XJ; Qi J; Wu XH; Wu Y; Tang YY; Ju SQ
Br J Cancer; 2014 Oct; 111(8):1482-9. PubMed ID: 25157833
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell-free DNA in serum as a biomarker of colorectal cancer.
da Silva Filho BF; Gurgel AP; Neto MÁ; de Azevedo DA; de Freitas AC; Silva Neto Jda C; Silva LA
J Clin Pathol; 2013 Sep; 66(9):775-8. PubMed ID: 23833048
[TBL] [Abstract][Full Text] [Related]
3. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
4. Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients.
Anzinger I; Nagel D; De Toni EN; Ofner A; Philipp AB; Holdt LM; Teupser D; Kolligs FT; Herbst A
Cancer Biomark; 2023; 37(4):237-248. PubMed ID: 37302022
[TBL] [Abstract][Full Text] [Related]
5. Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.
Zhu F; Ma J; Ru D; Wu N; Zhang Y; Li H; Liu X; Li J; Zhang H; Xu Y; Zhao J; Tang H; Wang Y; Fu W
J Oncol; 2021; 2021():5569783. PubMed ID: 34135960
[TBL] [Abstract][Full Text] [Related]
6. Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma.
El-Gayar D; El-Abd N; Hassan N; Ali R
Asian Pac J Cancer Prev; 2016; 17(3):939-44. PubMed ID: 27039817
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
8. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.
Umetani N; Kim J; Hiramatsu S; Reber HA; Hines OJ; Bilchik AJ; Hoon DS
Clin Chem; 2006 Jun; 52(6):1062-9. PubMed ID: 16723681
[TBL] [Abstract][Full Text] [Related]
9. Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers.
Danese E; Montagnana M; Minicozzi AM; De Matteis G; Scudo G; Salvagno GL; Cordiano C; Lippi G; Guidi GC
Clin Chem Lab Med; 2010 Nov; 48(11):1665-8. PubMed ID: 20704532
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.
Yu D; An G; Xu L
Clin Lab; 2016 Oct; 62(10):1947-1953. PubMed ID: 28164530
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free-DNA concentration is a good biomarker for diagnosis of colorectal cancer in Mexican patients.
Saucedo-Sariñana AM; Lugo-Escalante CR; Barros-Núñez P; Marín-Contreras ME; Pineda-Razo TD; Mariscal-Ramírez I; Gallegos-Arreola MP; Rosales-Reynoso MA
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):1-8. PubMed ID: 36227685
[TBL] [Abstract][Full Text] [Related]
13. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
14. Highly sensitive diagnostic method for colorectal cancer using the ratio of free DNA fragments in serum.
Arakawa S; Ozawa S; Ando T; Takeuchi H; Kitagawa Y; Kawase J; Oshima H; Nagata H; Atsuta K; Yoshida R; Kawabe N; Umemoto S; Morise Z; Horiguchi A
Fujita Med J; 2019; 5(1):14-20. PubMed ID: 35111495
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
17. Serum Expression of
Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
19. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
